Pharmaceutical Market Europe • November 2025 • 5

CONTENTS

November 2025

NEWS & COLUMNS


6-7 NEWS
Pfizer pays $10bn for Metsera after bidding war with Novo Nordisk; Merck acquires Cidara for almost $9.2bn

8-9 NEWS
Novo Nordisk agrees to lower certain US drug prices; Lilly agrees to lower costs for US patients

10-11 DERMATOLOGY NEWS
Sanofi’s Dupixent recommended by CHMP for CSU; UCB’s positive early trial results for atopic dermatitis

12 DARWIN'S MEDICINE
Are bad habits sabotaging your strategic decisions?

13 PATIENT INSIGHT: HUMAN VS AI
Why ethical guard rails are essential

14 HEALTHCARE COMPANY PARTNERSHIPS
Overcoming cultural and organisational divides

15 THE TRUST CRISIS
How pharma must evolve to engage Gen Z HCPs

FEATURES


16-18 ESMO 2025: ‘MANY JOURNEYS
More than 35,000 delegates packed into Messe Berlin, marking the congress’s 50th anniversary, but it wasn’t a nostalgic celebration; it was a declaration that oncology’s next era is already here

20-22 CARDIOVASCULAR DISEASE – OPTIMISING THERAPIES TO IMPROVE OUTCOMES
Cardiovascular diseases (CVDs) still account for about one-third of all deaths worldwide, totalling around 20 million deaths each year and affecting over 500 million people globally. We have effective drugs. So why are we stuck?

24-25 GLOBAL PHARMA PRICING – BRIDGING THE AFFORDABILITY GAP
As global pricing reforms squeeze margins and reshapes supply chains, manufacturers can restore confidence through smarter systems, connected data and greater operational resilience – and the path to affordability starts on the factory floor

COMMUNIQUE
MARKETING & COMMS


28-29 GLOBAL REGULATORY STANDARDS – STRATEGIES TO ACHIEVE REGULATORY HARMONISATION
While regulators may share high-level principles, the US, EU and UK operate under different systems, with distinct expectations for clinical evidence, timelines and commercial readiness.
Regulatory harmonisation remains a goal, but region-specific strategies are essential

32-34 SETTING OUT – WHY OMNICHANNEL SUCCESS IS ABOUT ORCHESTRATION
Today’s audiences listen simultaneously to multiple channels, from social media to digital detailing, which leak into each other like a commuter’s headphones on a crowded train. Like a symphony set in a musical key, well-defined marketing objectives anchor the components of an omnichannel campaign, enabling the various players to harmonise

CAREERS & RECRUITMENT


36-37 APPOINTMENTS
Each month, we bring you the latest news on job changes in the pharma sector. This month, we are highlighting change at ArtBio, Neogap Therapeutics and BioDuro

0